05.01.2015 • NewsActegaAltanaMergers & Acquisitions (M&A)

Germany’s Altana Acquires two Brazilian Companies

In a move to expand its position in the Brazilian market, the Actega division of German specialty chemicals producer Altana has acquired two owner-operated companies, Premiata and Overlake, both based in the state of São Paulo.

Premiata's two facilities employing 140 people operate under the name of Premiata Tintas and Premiata Especialidades Químicas and specialize respectively in printing inks and coatings for the packaging industry. Overlake is an over-print varnishes specialist with 70 employees at one site.

"As both companies focus entirely on specialty chemicals and tailored customer solutions they are a perfect match for Altana," said Martin Babilas, member of the Wesel-based company's management board.

Going forward, all Brazilian businesses of Altana's Actega division will be concentrated in the newly established national entity Actega do Brasil.

"Taking over Premiata and Overlake means we can significantly expand our portfolio of solutions particularly for the Brazilian packaging industry," said Actega division president Roland Peter.

The company already has a production and research site in Brazil run by its Elantas division, which develops and distributes insulating materials for the electrical and electronics sectors.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.